A detailed history of Engineers Gate Manager LP transactions in Bioventus Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 25,606 shares of BVS stock, worth $314,697. This represents 0.01% of its overall portfolio holdings.

Number of Shares
25,606
Previous 11,760 117.74%
Holding current value
$314,697
Previous $67,000 355.22%
% of portfolio
0.01%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.73 - $11.95 $79,337 - $165,459
13,846 Added 117.74%
25,606 $305,000
Q2 2024

Aug 14, 2024

BUY
$3.96 - $6.93 $46,569 - $81,496
11,760 New
11,760 $67,000
Q1 2022

May 16, 2022

SELL
$11.65 - $15.28 $271,363 - $355,917
-23,293 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$12.37 - $16.77 $288,134 - $390,623
23,293 New
23,293 $338,000
Q2 2021

Aug 16, 2021

SELL
$13.75 - $18.8 $331,622 - $453,418
-24,118 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$11.49 - $19.21 $277,115 - $463,306
24,118 New
24,118 $369,000

Others Institutions Holding BVS

About Bioventus Inc.


  • Ticker BVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 61,664,200
  • Market Cap $758M
  • Description
  • Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...
More about BVS
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.